表紙
市場調查報告書

自訂重組蛋白質的生產服務的全球市場 - 規模,佔有率,展望及機會分析

Custom Recombinant Protein Production Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

出版商 Coherent Market Insights 商品編碼 883781
出版日期 內容資訊 英文 190 Pages
商品交期: 2-3個工作天內
價格
Back to Top
自訂重組蛋白質的生產服務的全球市場 - 規模,佔有率,展望及機會分析 Custom Recombinant Protein Production Services Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
出版日期: 2019年06月20日內容資訊: 英文 190 Pages
簡介

這份報告提供全球自訂重組蛋白質的生產服務市場的相關調查,提供市場動態,法規及趨勢分析,表現系統·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 研究的目的與前提

  • 研究目的
  • 假設
  • 簡稱

第2章 市場視野

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 各表現系統
    • 各終端用戶
    • 各地區
  • COM (Coherent Opportunity Map)

第3章 市場動態,法規及趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 返還方案
  • PEST分析
  • 法規方案
  • 與聯盟協定
  • 市場趨勢

第4章 全球自訂重組蛋白質的生產服務市場 :各表現系統

  • 簡介
  • 哺乳類
  • 細菌
  • 昆蟲
  • 酵母
  • 其他

第5章 全球自訂重組蛋白質的生產服務市場 :各終端用戶

  • 簡介
  • 研究機關
  • 生物科技與製藥公司
  • 受託研究機構
  • 其他

第6章 全球自訂重組蛋白質的生產服務市場 :各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭情形

  • 熱圖分析
  • 企業簡介
    • GenScript Biotech Corporation
    • Applied Biological Materials Inc.
    • Eurofins Pharma Discovery Services
    • Abgent
    • OriGene Technologies, Inc.
    • Crown Bioscience, Inc.
    • BPS Bioscience, Inc.
    • ProteoGenix
    • Kempbio, Inc.
    • Novoprotein
    • Premas Biotech
    • Trenzyme GmbH
    • Atum
    • Novus Biologicals, LLC
    • Icosagen AS
    • LakePharma, Inc.
    • Proteos, Inc.
    • Aldevron
    • Sino Biological Inc.
  • 分析師的意見

第8章 章節

  • 參考文獻
  • 調查方法
  • 本公司與銷售方面

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Recombinant proteins are used in development of novel therapies for severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technology. Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research.

Market Dynamics:

Increasing demand for recombinant proteins for basic research has supported growth of the custom recombinant protein production services market. Recombinant therapeutic proteins are one of the fast-growing areas in molecular medicine. Various biopharmaceutical companies are focusing on development of biologics and subsequently biosimilars. Moreover, increasing expenditure in research has supported the market growth. The R&D spending of the U.S. is around 2.7% of its Gross Domestic Products (GDP) with highest R&D investments observed in the biotechnology segment in 2014, according to American Pharmaceutical Review.

Moreover, major players in the market are focused on launching new facilities to cater to increasing demand for research and development, which is expected to drive the market growth. For instance, in 2016, ATUM established a new state-of-the-art bio-production facility in Newark, California, for rapid expansion and to provide better services to the customers.

However, high cost of protein expression systems and complex manufacturing procedures are the major factors restraining the market growth over the forecast period. For instance, the price of recombinant protein production services varies from US$ 500 to US$ 5000 per milligram depending upon the protein production expression systems, species of the proteins, and the family to which these recombinant proteins belong.

Key features of the study:

  • This report provides in-depth analysis of the custom recombinant protein production services market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global custom recombinant protein production services market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, and Sino Biological Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the custom recombinant protein production services market

Detailed Segmentation:

  • Global Custom Recombinant Protein Production Services Market, By Expression System:
    • Mammalian
    • Bacteria
    • Insect
    • Yeast
    • Others
  • Global Custom Recombinant Protein Production Services, By End User:
    • Research Institutes
    • Biotechnology and Pharmaceutical Companies
    • Contract Research Organizations
    • Others
  • Global Custom Recombinant Protein Production Services Market, By Geography:
    • North America
      • By Expression System:
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
      • By End User:
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Expression System:
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
      • By End User:
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Expression System:
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
      • By End User:
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Expression System:
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
      • By End User:
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Expression System:
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
      • By End User:
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Expression System:
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
      • By End User:
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • GenScript Biotech Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Applied Biological Materials Inc.
    • Eurofins Pharma Discovery Services
    • Abgent
    • OriGene Technologies, Inc.
    • Crown Bioscience, Inc.
    • BPS Bioscience, Inc.
    • ProteoGenix
    • Kempbio, Inc.
    • Novoprotein
    • Premas Biotech
    • Trenzyme GmbH
    • Atum
    • Novus Biologicals, LLC
    • Icosagen AS
    • LakePharma, Inc.
    • Proteos, Inc.
    • Aldevron
    • Sino Biological Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Expression System
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Pest Analysis
  • Regulatory Scenario
  • Collaborations and Agreements
  • Market Trends

4. Global Custom Recombinant Protein Production Services Market, By Expression System, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Mammalian
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Bacteria
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Insect
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Yeast
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Custom Recombinant Protein Production Services Market, By End User, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Custom Recombinant Protein Production Services Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Expression System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Expression System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Expression System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Expression System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Expression System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Expression System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • GenScript Biotech Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Applied Biological Materials Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eurofins Pharma Discovery Services
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abgent
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • OriGene Technologies, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Crown Bioscience, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BPS Bioscience, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ProteoGenix
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kempbio, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novoprotein
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Premas Biotech
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Trenzyme GmbH
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Atum
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novus Biologicals, LLC
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Icosagen AS
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • LakePharma, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Proteos, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aldevron
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sino Biological Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top